You are here
Medtech startup set to revolutionise cancer diagnostics
A SINGAPORE-based medtech startup that is looking to bring low-cost, simple-to-use cancer diagnostics tests to the masses, is set to revolutionise the global cancer diagnostics market that is projected to hit some US$168.6 billion in 2020.
VolitionRx has developed a blood
- CALL +65 6388 3838
- EMAIL email@example.com